# National Health Investors, Inc. (NHI) · Edgar & Edgarette company card

> National Health Investors (NHI) grew revenue 12.1% in FY2025 to $376 million, equity 54.4% of assets, and dividend per share up 1 year running. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 877860 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/NHI) · [JSON](https://www.pops4.com/boards/company/NHI.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $376M |
| Revenue growth, 1 year | 12.1% |
| Revenue growth per year | 5.9% |
| Operating margin | — |
| Net margin | 37.9% |
| Operating cash flow | $237M |
| Capital spending | $347M |
| Free cash flow | −$110M |
| Cash | $20M |
| Long-term debt | $1.2B |
| Total assets | $2.8B |
| Total equity | $1.5B |
| Equity ÷ assets | 54.4% |
| Return on equity | 9.3% |
| Dividend per share | $3.64 |
| Dividend years rising | 1 |

## Readings, computed from those figures

- Piotroski F: 5 of 9 (middling)
- Health Harbor boat: Sound ship · one warning sign · free cash flow was negative: capital spending outran operating cash (-$110.5M in FY2025)
- Cash Compass: Cash cow now · steady, with strong cash arriving today

## Edgarette's reading

Exposure: revenue $375.6M (FY2025), total debt $1.2B. Experience: revenue up 12.1% on the year, up 5.9% a year over 4 years. Soundness: equity 54.4% of assets, return on equity 9.3%, payout 119.4% of profit, dividend per share up 1 year running. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $348.9M and $481.5M next year (method v4.1: its own 4-year record of growth weighed at 50% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $321.6M to $524.1M. A statistical range, not company guidance. Against peers (79 filers, $50M+ revenue, real estate investment trusts): growth 12.1% against 3.7%.

Range logged 2026-11-16, receipt ba0a6ad29be4e855, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 7, latest 2026-11-13 ([filing](https://www.sec.gov/Archives/edgar/data/877860/000087786026000230/0000877860-26-000230-index.htm))

## Recent filings

- 8-K · filed 2026-11-13 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/877860/000087786026000230/0000877860-26-000230-index.htm)
- 8-K · filed 2026-11-09 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/877860/000087786026000226/0000877860-26-000226-index.htm)
- 8-K · filed 2026-11-09 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/877860/000087786026000223/0000877860-26-000223-index.htm)
- 8-K · filed 2026-11-09 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/877860/000087786026000222/0000877860-26-000222-index.htm)
- 10-Q · filed 2026-11-09 · [filing](https://www.sec.gov/Archives/edgar/data/877860/000087786026000221/0000877860-26-000221-index.htm)
- 8-K · filed 2026-08-27 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/877860/000087786026000205/0000877860-26-000205-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000877860.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=877860

## Cite

POPS4, Edgar & Edgarette: National Health Investors, Inc. (NHI) company card, from the company's own SEC filings, accessed 2026-11-16, https://www.pops4.com/boards/company/NHI. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.

